再生医療市場：タイプ別、用途別-2024年～2030年の世界予測

再生医療市場規模は2023年に230億2,000万米ドルと推計され、2024年には283億5,000万米ドルに達し、CAGR 23.76％で2030年には1,024億米ドルに達すると予測されています。

再生医療は、細胞、組織、臓器の再生、修復、置換を促進するために工学と生命科学の原理を応用する学際的分野です。細胞治療、遺伝子治療、組織工学、生体材料や成長因子の応用など、さまざまなアプローチを組み合わせて、損傷した組織や病気の組織の機能回復を目指します。急速に発展しているこの分野は、身体自身の修復メカニズムを利用したり、実験室で機能的な組織を作ったりすることで、様々な病状を治療することが期待されています。再生医療市場は、慢性疾患や遺伝性疾患の有病率の増加、細胞治療や組織工学の進歩、画期的な治療法につながる研究開発への多額の投資などの要因によって推進されています。さらに、世界人口の高齢化と革新的な再生治療へのニーズも市場の拡大に寄与しています。しかしながら、承認プロセスを遅らせる厳しい規制政策、治療や研究に関連する高コスト、幹細胞使用に関する倫理的懸念などの障害に直面しています。さらに、個別化医療の進歩により、オーダーメイド治療の可能性が広がっています。新興市場もまた新たな拡大の道を提供し、技術革新はより良い治療結果を可能にし続け、やがては治療費の削減につながる可能性もあります。

タイプ個別化治療における細胞ベースの免疫療法と細胞治療製品の重要な応用

再生医療は、細胞ベースの免疫療法と細胞療法製品で治療状況に革命をもたらしています。これらの先進的な治療法は、細胞を用いて病気を治療するもので、ドナーから採取して複数の患者に投与する同種製品や、同じ個人から採取して治療に用いる自家製品などがあります。遺伝子治療製品は、再生医療の重要な要素を象徴しており、病気の治療や予防のために生物の遺伝子を直接操作することに焦点を当てています。これらの治療法は、患者の細胞内に遺伝物質を導入、除去、変化させることによって機能し、遺伝子の異常を修正したり、治療用タンパク質を発現させたり、機能不全の遺伝子を無効にしたりする手段を提供します。再生医療の広範なカテゴリーには、低分子医薬品と生物製剤が含まれます。低分子は一般的に、生物学的プロセスを調節することができる明確に定義された低分子化合物であり、一方、生物製剤は抗体、組換えタンパク質、ペプチドなどの様々な製品を包含します。これらの薬剤は多くの場合、細胞経路に影響を与えることによって再生プロセスを刺激したり誘導したりする作用を持ち、複雑な組織や臓器の修復において特に効果的です。組織工学的製品の開発は、ヒト組織の修復、置換、維持、機能強化を目的とした再生医療における変革的分野です。足場、細胞、生物学的に活性な分子を利用する組織工学的アプローチは、患者の組織と一体化できる構築物を綿密に設計し、臓器不足の解決策を提供し、従来の移植や再建手術に代わる選択肢を提供します。

応用心血管疾患における再生医療の重要性の高まり

再生医療は、損傷した心臓組織を修復または置換するための細胞治療、組織工学、遺伝子編集を通じて、心血管疾患に対する潜在的な治療法を提供します。再生医療が心臓病学で好まれるのは、主に侵襲的な処置を最小限に抑えることができることと、心不全や末梢動脈疾患などの症状において長期的な回復が期待できることに起因しています。糖尿病は世界中で数百万人が罹患しており、再生医療はインスリンを産生するβ細胞の回復や膵臓組織の再生による治療の可能性を提供します。特に、自己免疫反応によってβ細胞が破壊され、患者が生涯にわたるインスリン療法を必要とする1型糖尿病に対しては、このような革新的な治療法が強く求められています。筋骨格系障害には、骨、筋肉、結合組織に影響を及ぼす幅広い疾患が含まれます。軟骨再生や骨修復などの再生医療アプリケーションは、怪我をした後や変形性関節症などの退行性疾患の場合、治癒時間や機能回復の改善に対する多大なニーズに応えるものです。さらに、再生医療は、視力を回復させたり、病気の進行やその他の眼疾患を食い止めたりするための細胞ベースの治療法や組織工学的ソリューションを提供することができます。腫瘍学は、再生医療ががん治療に革命をもたらす可能性のある重要な分野です。身体自身の治癒メカニズムを活用することで、免疫系を刺激し、がん細胞を標的にして破壊することができます。このような治療法は、従来の治療法と比較して、個別化された性質と副作用の少なさから、ますます好まれるようになってきています。創傷治療もまたヘルスケアに欠かせない要素であり、特に糖尿病や血管疾患によって治癒が損なわれている患者にとっては重要です。再生医療の分野では、生体工学的組織や成長因子の開発を通じて、慢性および急性の創傷の治癒をより迅速かつ効果的に促進する治療法の必要性に取り組んでいます。

地域の洞察

南北アメリカの再生医療市場は、再生医療と関連治療に対する広範な研究開発活動、強力な財政投資、政府の支援政策により著しい成長を示しています。バイオテクノロジーや製薬セクターの大手企業の存在と、組織工学や幹細胞治療における技術的進歩が、この地域における市場の堅調な拡大に寄与しています。欧州、中東・アフリカ（EMEA）地域は、強力なヘルスケアシステムと再生治療の選択肢に対する意識の高まりに支えられ、再生医療の採用が進んでいます。幹細胞研究や遺伝子治療への多額の投資と再生医療製品の臨床試験の急増が、欧州の市場成長をさらに後押ししています。中東とアフリカも、投資と共同研究の増加により、市場での存在感を徐々に高めています。アジア太平洋（APAC）地域は、政府の積極的な取り組み、医療費の増加、高度な治療を求める患者の増加により、急速な市場拡大を示しています。同地域における再生医療製品の研究施設や製造施設の数が増加していることも、APAC市場の明るい見通しに拍車をかけています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、再生医療市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、再生医療市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.再生医療市場の市場規模および予測は？

2.再生医療市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.再生医療市場の技術動向と規制枠組みは？

4.再生医療市場における主要ベンダーの市場シェアは？

5.再生医療市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 幹細胞技術、遺伝子治療、組織工学の導入の増加
    • 再生医療調査への政府投資の増加
    • 民間企業による研究開発活動の増加と相まって製品承認
  • 抑制要因
    • 幹細胞に関する高コストと規制の問題と再生医療
  • 機会
    • 再生医療生物製剤における技術的進歩
    • 臓器移植と骨移植の需要増加
  • 課題
    • 研究開発における胚性幹細胞の使用に関する倫理的問題
• 市場セグメンテーション分析
  • タイプ：個別化治療における細胞ベースの免疫療法および細胞治療製品の重要な応用
  • 応用：心血管疾患における再生医療の重要性の高まり
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 再生医療市場：タイプ別

• 細胞ベースの免疫療法および細胞治療製品
• 遺伝子治療製品
• 低分子・生物製剤
• 組織工学製品

第7章 再生医療市場：用途別

• 心臓血管
• 糖尿病
• 筋骨格障害
• 眼疾患
• 腫瘍学
• 創傷ケア

第8章 南北アメリカの再生医療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の再生医療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの再生医療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • 4DMTがFDAからウェット AMDの硝子体内治療用遺伝子医薬品 4D-150の先進治療指定を取得
  • シスメックスとJCRファーマの合弁会社アライドセルが再生医療製品の早期社会実装を推進する新たなパイプラインを獲得
  • マウントサイナイが再生医療研究所を設立
• 戦略分析と提言

第12章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
• FIGURE 2. REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. REGENERATIVE MEDICINE MARKET DYNAMICS
• FIGURE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 20. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE & BIOLOGIC, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE & BIOLOGIC, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 45. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 46. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 47. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 48. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 49. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 50. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 51. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 52. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 53. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 54. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 55. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 56. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 57. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 58. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 59. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 60. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 61. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 62. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 63. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 64. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 65. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 66. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 67. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 68. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 71. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 72. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 73. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 76. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 80. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 84. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 85. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 86. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 87. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 88. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 89. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 90. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 91. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 92. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 93. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 94. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 95. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 96. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 97. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 98. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 99. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 100. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 101. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 102. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 103. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 104. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 105. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 106. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 107. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 108. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 109. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 110. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 111. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 112. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 113. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 114. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 115. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 116. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 117. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 118. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 119. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 120. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 121. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 122. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 123. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 124. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 125. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 126. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 127. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 128. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 129. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 130. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 131. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 132. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 134. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 136. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 137. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 138. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 139. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 140. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 141. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 142. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 143. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 144. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 145. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 146. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 147. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 148. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 149. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 150. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 151. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 152. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 153. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 154. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 155. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 156. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 164. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 165. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 166. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 167. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 168. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 169. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 170. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 171. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 172. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 173. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 174. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 175. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 176. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 177. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 178. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 179. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 180. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 181. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 182. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 183. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 184. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 185. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 186. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 187. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 188. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 189. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 190. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 191. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 192. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 193. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 194. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 195. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 196. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 197. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 198. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 199. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 200. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 201. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 202. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 203. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 204. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 205. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 206. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 207. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 208. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 209. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 210. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 211. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 212. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 213. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 214. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 215. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 216. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 217. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 218. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 219. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 220. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 221. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 222. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 223. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 224. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 225. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 226. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 227. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 228. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 229. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 230. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 231. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 232. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 233. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 234. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 235. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 236. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 237. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 238. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 239. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 240. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 241. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 242. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 244. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 245. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 246. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 247. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 248. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 250. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 252. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 253. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 254. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 255. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 256. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 257. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 258. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 259. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 260. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 261. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 262. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 263. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 264. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 265. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 266. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 267. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 268. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 269. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 270. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 271. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 272. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 273. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 274. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 275. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 276. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 277. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 278. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 281. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 282. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 283. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 284. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 286. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 287. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 288. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 289. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 290. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 291. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 292. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

[197 Pages Report] The Regenerative Medicine Market size was estimated at USD 23.02 billion in 2023 and expected to reach USD 28.35 billion in 2024, at a CAGR 23.76% to reach USD 102.40 billion by 2030.

Regenerative medicine is an interdisciplinary field that applies engineering and life science principles to promote regeneration, repair, or replacement of cells, tissues, or organs. It aims to restore the function of damaged or diseased tissues using a combination of approaches, including cell therapy, gene therapy, tissue engineering, and the application of biomaterials and growth factors. This rapidly evolving field holds the promise for treating various medical conditions by harnessing the body's own repair mechanisms or by creating functional tissues in the laboratory. The market for regenerative medicine is propelled by factors such as the increasing prevalence of chronic diseases and genetic disorders, advances in cellular therapy and tissue engineering, and significant investments in research and development that lead to breakthrough therapies. Additionally, the aging global population and its need for innovative regenerative treatments contribute to the expansion of the market. However, regenerative medicine faces obstacles, including stringent regulatory policies that slow down approval processes, high costs associated with therapies and research, and ethical concerns regarding stem cell use. Moreover, personalized medicine advancements open up possibilities for tailored treatments. Emerging markets are also providing new avenues for expansion, and technological innovations continue to enable better outcomes and potentially lower treatment costs over time.

Type: Significant applications of cell-based immunotherapies and cell therapy products in personalized treatment

Regenerative medicine is revolutionizing the therapeutic landscape with cell-based immunotherapy and cell therapy products. These advanced therapies involve using cells to treat diseases, with allogeneic products derived from a donor and administered to multiple patients and autologous products, which are harvested from and used to treat the same individual. Gene therapy products epitomize a significant component of regenerative medicine, focusing on the direct manipulation of an organism's genes to treat or prevent disease. These therapies work by introducing, removing, or altering genetic material within a patient's cells, thereby providing a means to correct genetic abnormalities, expressing therapeutic proteins, or disabling malfunctioning genes, and have shown immense potential in the treatment of genetic disorders, certain types of cancer, and viral infections. A broad category within regenerative medicine includes small molecule and biologics. Small molecules are typically well-defined, low molecular weight compounds that can modulate biological processes, while biologics encompass a range of products such as antibodies, recombinant proteins, and peptides. These agents often act to stimulate or guide the regeneration process by influencing cellular pathways and can be particularly effective in complex tissue and organ repair. The development of tissue-engineered products is a transformative area within regenerative medicine aimed at repairing, replacing, maintaining, or enhancing the function of human tissues. Utilizing scaffolds, cells, and biologically active molecules, tissue engineering approaches meticulously design constructs that can integrate with patient tissues, offering solutions for organ shortages and providing alternatives to traditional transplants and reconstructive surgeries.

Application: Growing significance of regenerative medicines for cardiovascular diseases

Regenerative medicine offers potential treatments for cardiovascular diseases through cell therapy, tissue engineering, and gene editing to repair or replace damaged heart tissue. Preference for regenerative medicine in cardiology primarily stems from its ability to minimize invasive procedures and its promise for long-term recovery in conditions including heart failure and peripheral artery disease. Diabetes affects millions worldwide, and regenerative medicine offers the possibility of restoring insulin-producing beta cells or regenerating pancreatic tissue to treat it. There is a strong need for such innovative treatments, particularly for type 1 diabetes, where autoimmune responses destroy beta cells, and patients require lifelong insulin therapy. Musculoskeletal disorders include a wide range of conditions affecting bones, muscles, and connective tissue. Regenerative medicine applications, such as cartilage regeneration and bone repair, address the tremendous need for improved healing times and functional recovery post-injury or in the case of degenerative diseases, including osteoarthritis. Moreover, regenerative medicine can provide cell-based therapies and tissue engineering solutions to restore sight or halt disease progression and other ocular disorders. Oncology is a critical area where regenerative medicine can potentially revolutionize cancer treatment. By leveraging the body's own healing mechanisms, it can stimulate the immune system to target and destroy cancer cells. There is an increasing preference for these treatments owing to their personalized nature and their potential for fewer side effects compared to traditional therapies. Wound care is another essential component of healthcare, particularly for patients with diabetes or vascular diseases that impair healing. The field of regenerative medicine, through the development of bioengineered tissues and growth factors, addresses the need for therapies that promote faster and more effective healing of chronic and acute wounds.

Regional Insights

The regenerative medicine market in the Americas has shown significant growth with extensive research and development activities, strong financial investments, and supportive government policies for regenerative medicine and related therapies. The presence of significant players in the biotechnology and pharmaceutical sectors, coupled with technological advancements in tissue engineering and stem cell therapy, has contributed to the robust expansion of the market in this region. Europe, the Middle East, and Africa (EMEA) region exhibit a progressive adoption of regenerative medicine, backed by strong healthcare systems and rising awareness of regenerative treatment options. Europe, with substantial investments in stem cell research and gene therapy and the upsurge in clinical trials for regenerative products, has further fueled the market growth. The Middle East and Africa are also gradually expanding their market presence with increasing investments and collaborations. The Asia-Pacific (APAC) region has illustrated rapid market expansion with favorable government initiatives, rising healthcare expenditure, and a growing patient population looking for advanced treatments. The increasing number of research facilities and manufacturing units for regenerative products in this region adds to the positive outlook of the APAC market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Regenerative Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Regenerative Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include 4D Molecular Therapeutics, Inc., Allergan PLC, Amgen Inc., Astellas Pharma Inc., Athersys, Inc., Bayer AG, CMIC HOLDINGS Co., LTD., Editas Medicine, Inc., FUJIFILM Cellular Dynamics, Inc., Gilead Sciences, Inc., Integra LifeSciences Holdings Corporation, JCR Pharmaceuticals Co., Ltd., Medtronic PLC, Mimedx Group, Novartis AG, Organogenesis Inc., Osiris Therapeutics, Inc. by Smith & Nephew PLC, REPROCELL Inc., SanBio Company Limited, Sartorius AG, Sumitomo Pharma Co., Ltd., Sysmex Corporation, Takeda Pharmaceutical Co. Ltd., Tenaya Therapeutics, Inc., Vericel Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc..

Market Segmentation & Coverage

This research report categorizes the Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Cell-Based Immunotherapy & Cell Therapy Products
    • Allogeneic Products
    • Autologous Products

• Gene Therapy Products
• Small Molecule & Biologic
• Tissue-Engineered Products

• Application
  • Cardiovascular
  • Diabetes
  • Musculoskeletal Disorders
  • Ocular Disorders
  • Oncology
  • Wound Care

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Regenerative Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Regenerative Medicine Market?

3. What are the technology trends and regulatory frameworks in the Regenerative Medicine Market?

4. What is the market share of the leading vendors in the Regenerative Medicine Market?

5. Which modes and strategic moves are suitable for entering the Regenerative Medicine Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing adoption of stem cell technologies, gene therapies, and tissue engineering
    • 5.1.1.2. Rising government investments in regenerative medicine research
    • 5.1.1.3. Product approval coupled with increasing R&D activities by private players
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and regulatory issues pertaining to stem cell and regenerative medicine
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in regenerative medicine biologics
    • 5.1.3.2. Growing demand for organ transplantation and bone grafting
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical issues related to the use of embryonic stem cells in R&D
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Significant applications of cell-based immunotherapies and cell therapy products in personalized treatment
  • 5.2.2. Application: Growing significance of regenerative medicines for cardiovascular diseases
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Regenerative Medicine Market, by Type

• 6.1. Introduction
• 6.2. Cell-Based Immunotherapy & Cell Therapy Products
• 6.3. Gene Therapy Products
• 6.4. Small Molecule & Biologic
• 6.5. Tissue-Engineered Products

7. Regenerative Medicine Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular
• 7.3. Diabetes
• 7.4. Musculoskeletal Disorders
• 7.5. Ocular Disorders
• 7.6. Oncology
• 7.7. Wound Care

8. Americas Regenerative Medicine Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Regenerative Medicine Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Regenerative Medicine Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. 4DMT Receives FDA Regenerative Medicine Advanced Therapy Designation for 4D-150 Genetic Medicine for Intravitreal Treatment of Wet AMD
  • 11.3.2. AlliedCel, a Joint Venture Between Sysmex and JCR Pharmaceuticals, Has Acquired a New Pipeline to Promote the Early Social Implementation of Regenerative Medicine Products
  • 11.3.3. Mount Sinai Launches Institute for Regenerative Medicine
• 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

• 12.1. Key Company Profiles
• 12.2. Key Product Portfolio